Ascaris and <font color="red">growth_1</font> <font color="red">rates_1</font> <font color="red">:_1</font> a randomized trial of treatment . 
<br>
<br> <font color="red">Three_5</font> <font color="red">hundred_5</font> <font color="red">forty_5</font> <font color="red">-_5</font> <font color="red">one_5</font> <font color="red">Tanzanian_5</font> <font color="red">preschool_5</font> <font color="red">children_5</font> were randomly assigned to levamisole or placebo treatment given at three - month intervals . Weights and heights were measured at the tri - monthly treatment visits for a period of one year . Among the <font color="red">273_3</font> <font color="red">children_4</font> <font color="red">who_1</font> <font color="red">were_1</font> <font color="red">seen_1</font> <font color="red">and_1</font> <font color="red">weighed_1</font> <font color="red">at_1</font> <font color="red">the_1</font> <font color="red">one_1</font> <font color="red">-_1</font> <font color="red">year_1</font> <font color="red">follow_1</font> <font color="red">-_1</font> <font color="red">up_1</font> <font color="red">visit_1</font> <font color="red">,_1</font> the rate of weight gain was 8 per cent greater for those receiving levamisole than for placebo - treated controls ( p = .06 ) . In <font color="red">78_2</font> <font color="red">children_3</font> <font color="red">known_1</font> <font color="red">to_1</font> <font color="red">be_1</font> <font color="red">infected_1</font> <font color="red">with_1</font> <font color="red">Ascaris_1</font> at baseline , the rate of weight gain was 21 per cent greater in <font color="red">children_1</font> treated with levamisole than in those receiving placebo ( p = .03 ) . The <font color="red">rate_1</font> <font color="red">of_1</font> <font color="red">height_1</font> <font color="red">gain_1</font> was no different for treatment and <font color="red">placebo_1</font> <font color="red">groups_1</font> <font color="red">._1</font>